retatrutide peptide from china Manufacturer Factory Retatrutide - Transforma Peptides

Experts to discuss the benefits of glucagon/GLP-1 receptor dual agonism gleaned from SYNCHRONIZE Lee Kaplan, MD, PhD, and other investigators will examine the basic science underlying injectable survodutide, as well as results from two of the four studies in the SYNCHRONIZE program

Knowing this connection helps you better prepare for and manage this side effect during your treatment journey

A dedicated single-injection 7.2 mg pen is expected later in 2026

Human clinical studies have shown promising results, including a 12-year randomized controlled trial demonstrating improved cardiovascular outcomes and reduced mortality in elderly subjects with accelerated aging [4]